FUCASO Shines in Real-World China Study at IMS | Expert Analysis

In a significant development, the 2026 International Myeloma Society (IMS) Annual Meeting showcased the exceptional performance of FUCASO in a real-world study in China.

The study involved 281 heavily pretreated.....

Subscribe for Full Access!

Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
Subscribe
Subscribe!
Share this Data

Other Sourcing Intelligence